Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy
Small · 2024
DOI: 10.1002/smll.202307147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Zhihong Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, P. R. China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Natural Science Foundation Youth Program, Shenzhen Outbound Postdoctoral Research Funding Project.
Abstract (Originalsprache)
Cancer immunotherapy has attracted considerable attention due to its advantages of persistence, targeting, and ability to kill tumor cells. However, the efficacy of tumor immunotherapy in practical applications is limited by tumor heterogeneity and complex tumor immunosuppressive microenvironments in which abundant of M2 macrophages and immune checkpoints (ICs) are present. Herein, two type‐I aggregation‐induced emission (AIE)‐active photosensitizers with various reactive oxygen species (ROS)‐generating efficiencies are designed and synthesized. Engineered extracellular vesicles (EVs) that express ICs Siglec‐10 are first obtained from 4T1 tumor cells. The engineered EVs are then fused with the AIE photosensitizer‐loaded lipidic nanosystem to form SEx@Fc‐NPs. The ROS generated by the inner type‐I AIE photosensitizer of the SEx@Fc‐NPs through photodynamic therapy (PDT) can convert M2 macrophages into M1 macrophages to improve tumor immunosuppressive microenvironment. The outer EV‐antigens that carry 4T1 tumor‐associated antigens directly stimulate dendritic cells maturation to activate different types of tumor‐specific T cells in overcoming tumor heterogeneity. In addition, blocking Siglec‐10 reversed macrophage exhaustion for enhanced antitumor ability. This study presents that a combination of PDT, immune checkpoints, and EV‐antigens can greatly improve the efficiency of tumor immunotherapy and is expected to serve as an emerging strategy to improve tumor immunosuppressive microenvironment and overcome immune escape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, P. R. China.
- Queen Mary School, Nanchang University, Nanchang, 330031, P. R. China.
- The Second Affiliated Hospital of Nanchang University, Nanchang, 330031, P. R. China.
- School of Public Health, Nanchang University, Nanchang, 330031, P. R. China.
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, P. R. China.
- Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab for Biomaterials, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, P. R. China.
ORCID-Profile: Guanjun Deng, Lintao Cai
Förderung
- National Natural Science Foundation of China
- Shandong Natural Science Foundation Youth Program
- Shenzhen Outbound Postdoctoral Research Funding Project
- Yantai Science and Technology Plan Project
- Affiliated Yantai Yuhuangding Hospital of Qingdao University
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Sun, Z., Sun, Z., Liu, J., Gao, X., Jiao, L., Zhao, Q., Chu, Y., Wang, X., Deng, G., & Cai, L. (2024). Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy. Small. https://doi.org/10.1002/smll.202307147
Vancouver
Sun Z, Sun Z, Liu J, Gao X, Jiao L, Zhao Q, et al. Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy. Small. 2024. doi:10.1002/smll.202307147
BibTeX
@article{Sun2024,
author = {Sun, Zhihong and Sun, Zhuokai and Liu, Jie and Gao, Xiaohan and Jiao, Liping and Zhao, Qi and Chu, Yongli and Wang, Xiaozhong and Deng, Guanjun and Cai, Lintao},
title = {Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202307147}
}
EUVIMED